Neogen Chemicals Share Price

Neogen Chemicals Limited is a leading manufacturer of specialty chemicals in India, primarily engaged in the production of bromine-based and lithium-based compounds. The company supplies Grignard reagents, inorganic lithium salts, and advanced intermediates for the pharmaceutical, agrochemical, electronics, and energy storage sectors. Neogen Chemicals operates multiple manufacturing facilities with significant reactor capacity, making it a key player in India’s specialty chemical industry. The Neogen Chemicals share price on the NSE and BSE is a reflection of how market participants respond to its performance and broader business developments within its industry. It captures the company’s sentiment among investors based on financial results, operational updates, macroeconomic factors, and trends specific to sectors. Movements in the share price͏ reveal how the market evaluates the company’s current position and its future prospects, making ͏it a key indicator of market perception across various industries.

Market sentiment around the Neogen Chemicals stock price often mirrors shifts in specialty chemical demand patterns, trends in the lithium-ion battery ecosystem, and investor views on the broader industrial sector’s growth prospects. Factors such as the pace of capacity expansion, competitive intensity from other specialty chemical manufacturers, raw material price fluctuations (particularly bromine and lithium), and government policies on “China+1” supply chain diversification influence near-term market valuation and medium-term earnings forecasts. All these factors must be closely monitored to have an idea about the Neogen Chemicals stock price movements.

Neogen Chemicals live share price provides real-time information about the last price traded, bid price, ask price, and volume traded. These indicators represent trading activity and liquidity and the reaction of investors to corporate announcements, quarterly results, and sector news. Constant monitoring of Neogen Chemicals live price helps observe short-term price fluctuations and understand how the stock is moving in relation to the broader market.

Furthermore, monitoring the Neogen Chemicals share price today helps investors understand real-time market sentiment, price volatility, and trading behaviour. It allows market participants to evaluate short-term performance, identify possible entry or exit points, and respond to news, quarterly results or sector trends that may affect the company’s valuation and overall investment outlook.

Neogen Chemicals Limited Company Fundamentals

a. Company Background

Neogen Chemicals Limited was incorporated in 1989. The company’s registered office is located in Thane, Maharashtra. Neogen Chemicals was originally incorporated as a private limited company under the name Neogen Chemicals Private Limited on March 7, 1989 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Mumbai, Maharashtra. The company was founded by Mr. Haridas T. Kanani, a chemical engineer from IIT Mumbai. Neogen’s primary activity involves the manufacturing of specialty chemicals with a strong presence in bromine-based and lithium-based chemistries. It initially focused on building expertise in bromination and Grignard reactions before gradually expanding into advanced chemistries. Neogen Chemicals supplies products to diverse industries including pharmaceuticals, agrochemicals, electronics, water treatment, construction, polymers, flavours and fragrances, and energy storage. The company has played a pivotal role in specialty chemical manufacturing in India. Over the years, Neogen Chemicals has significantly expanded its product portfolio to around 233 products and its manufacturing footprint to five advanced facilities across India. It operates in a competitive environment, with pricing and production governed by market forces and client requirements. The company has consistently focused on enhancing its technological capabilities to meet the growing demand for specialty chemicals in India and globally. Neogen Chemicals is the first Indian company to receive a global technology license from MU Ionic Solutions (MUIS), a joint venture between Mitsubishi Chemical Corporation and UBE Corporation, to produce up to 30,000 MT of electrolytes annually for lithium-ion batteries.

b. Product Lines

• Bromine-based compounds for pharmaceutical and agrochemical applications

• Lithium-based compounds including inorganic lithium salts for energy storage and pharmaceuticals

• Grignard reagents for various chemical synthesis applications

• Advanced intermediates for pharmaceutical industries and pesticide industries of world-class standards

• Electrolytes for lithium-ion batteries (under technology license from MUIS)

• Electrolyte salts and additives for advanced chemistry cells

• Custom synthesis and manufacturing (CSM) for global clients including leading companies in Japan and Europe

• Organic chemicals with reactor capacity increased from 1.30 m³ to 4.63 m³

• Inorganic chemicals with reactor capacity expanded from 2.40 m³ to 39 m³

• Specialty chemicals for electronics, water treatment, construction, polymers, and flavours & fragrances industries

• Alkylation, acylation, amination, oxidation, dehalogenation, silylation, halex reaction, Friedel-Crafts, couplings, and chlorination chemistry capabilities

c. Company Revenue Model

• Primary revenue from sale of specialty chemicals including bromine-based and lithium-based compounds

• Revenue from custom synthesis and manufacturing (CSM) services for global pharmaceutical and agrochemical clients

• Volume-driven revenue based on quantity of organic and inorganic chemicals produced and sold

• Pricing determined by raw material costs (bromine, lithium), manufacturing complexity, and market demand

• Revenue from advanced intermediates for pharmaceutical and pesticide industries

• Expanding product portfolio and customer base contributing to new revenue streams

• Focus on increasing value-added product share including electrolyte additives and lithium salts to drive higher margins

• Investment in new manufacturing facilities including greenfield battery materials facility to expand production capacity

• Revenue from both domestic Indian market and exports to 31 countries including USA, Europe, Japan, and Middle East

• Seasonal variations in chemical demand from end-user industries affecting revenue patterns throughout the year

• Government policies on specialty chemicals and “China+1” supply chain diversification influencing revenue stability

• Strategic acquisition of BuLi Chemicals India Pvt. Ltd. completed in May 2023 enhancing product portfolio

d. Geographic Presence

• Headquartered in Thane, Maharashtra with registered office at Office No. 1002, 10th Floor, Dev Corpora Bldg, Opp. Cadbury Junction, Off Pokhran Road No. 2, Khopat, Thane – 400601

• Manufacturing facilities located at Mahape, Navi Mumbai in Maharashtra; Karakhadi, Vadodara in Gujarat; Dahej SEZ in Gujarat; Patancheru, Sangareddy in Hyderabad; and Pakhajan, Bharuch (greenfield project site at Dahej PCPIR, Gujarat)

• Total land bank of approximately 192 acres across all manufacturing sites

• Global export presence across 31 countries including USA, Europe, Japan, and Middle East

• Strategic expansion through development of greenfield battery materials facility at Dahej PCPIR, Gujarat, spread across 65 acres to manufacture 30,000 MT of electrolytes and 3,000 MT of electrolyte salts and additives

• Operations primarily concentrated in western and southern India with global delivery footprint

• Dedicated R&D facilities at Vadodara and Mahape with a team of 46 members including PhDs

• Serves domestic and international markets with strong presence in pharmaceutical and agrochemical supply chains

e. Key Milestones

• 1989: Incorporated as Neogen Chemicals Private Limited on March 7, 1989

• 2000s: Developed significant expertise in bromine compounds, lithium compounds, and Grignard reagents

• 2021: Company listed on stock exchanges following IPO

• 2023: Entered into agreement with Livent Corporation (USA) to acquire 100% stake in BuLi Chemicals India Pvt. Ltd. in March 2023; acquisition completed in May 2023

• 2023: Received global technology license from MU Ionic Solutions (MUIS) for electrolyte production

• 2025: Hon’ble NCLT (Mumbai Bench) approved merger of BuLi Chem with Neogen in January 2025

• 2025: Company reported revenue of ₹783 crore in FY2024-25 with net profit of ₹48 crore

f. Industry Perspective

Neogen Chemicals Limited operates in the specialty chemicals industry, which is part of India’s broader chemical sector. Globally, the specialty chemicals market continues to expand, with specialty chemistries accounting for 20% of total global chemistries worth $4 trillion. In India, the specialty chemicals sector is poised for substantial growth. According to IMARC Group, the India specialty chemicals market size reached USD 67.0 billion in 2025 and is expected to reach USD 93.4 billion by 2034, exhibiting a growth rate (CAGR) of 3.65% during 2026-2034. The India specialty chemical market is experiencing significant growth driven by diverse end-user industries such as pharmaceuticals, agrochemicals, and personal care. According to industry reports, India’s specialty chemicals market is projected to grow to $64 billion by 2025 with a CAGR of 11-12%. The specialty chemicals industry is shifting from high-volume production to high-value, specialised products, driven by innovation and collaboration. India is emerging as a key beneficiary of global supply chain diversification under the “China+1” strategy adopted by multinationals. The government’s PCPIR policy supports the development of integrated manufacturing hubs. Demand is driven by rising domestic consumption, increasing export opportunities, government initiatives like the Production Linked Incentive (PLI) scheme for chemicals, and growing end-user industries including pharmaceuticals, agrochemicals, and electronics. Key challenges include raw material price volatility (bromine, lithium), intense competition from global and domestic players, stringent environmental regulations, and high capital expenditure requirements for new facilities.

Neogen Chemicals Limited Stock Market Presence: Listings & Index Representation

Neogen Chemicals is actively traded on India’s principal equity markets, with its shares listed on the National Stock Exchange of India (NSE) under the symbol NEOGEN and on the Bombay Stock Exchange (BSE) with the scrip code 542665. Its listing on both exchanges ensures that the Neogen Chemicals price is accessible to a wide investor base, encompassing both retail and institutional market participants. The company forms part of several benchmark indices that represent broad market segments. Neogen Chemicals is included in indices such as BSE SmallCap, BSE AllCap, BSE Industrials, BSE MidSmallCap, Nifty Microcap 250, and Nifty Total Market. Being represented in multiple indices enhances the visibility and liquidity of the Neogen Chemicals price, as index tracking funds and exchange traded strategies often adjust allocations in line with constituent revisions. It also allows investors to benchmark the company’s stock performance relative to broader market trends and peer groups, facilitating cross sectional comparisons within India’s specialty chemicals landscape. The inclusion of Neogen Chemicals in these indices reflects its market capitalisation and trading depth, which are key factors market participants consider when evaluating long term investment prospects and the responsiveness of the Neogen Chemicals price to corporate and industry developments. The company’s ISIN code is INE136S01016 and face value is Rs 10 per share.

Neogen Chemicals Limited Stock Performance and Share Price History

The Neogen Chemicals price has exhibited significant volatility over the past decade, shaped by the company’s position in India’s specialty chemicals sector and broader industry cycles. The Neogen Chemicals share price recorded a negative total return of approximately -27.12% over the last 1 year and -7.72% over the last 3 years, underperforming broader market indices and reflecting near-term headwinds including margin pressures and demand moderation. The Neogen Chemicals share price delivered a 5-year total return of 49.45% and a 10-year total return of 448.65%, demonstrating substantial long-term wealth creation despite recent underperformance. The Neogen Chemicals share price reached a 52-week high of 1,797.00 and a 52-week low of 967.00, indicating a wide trading range and substantial price fluctuations. The Neogen Chemicals share price recorded a strong rally in 2021, delivering a substantial positive annual return of 127.93%, while the subsequent period has seen the Neogen Chemicals stock price moderate and correct from its peak levels. The Neogen Chemicals share price has shown a 1-month return of approximately -19.44% and a 3-month return of 2.09%, indicating mixed short-term momentum.

The Neogen Chemicals price has been particularly responsive to quarterly earnings releases and corporate announcements. When the company reported the strategic acquisition of BuLi Chemicals and the technology license from MUIS for electrolyte production, the Neogen Chemicals stock price showed a positive reaction. The Neogen Chemicals stock price has shown a pattern of strong positive momentum in periods when the company’s capacity expansion exceeded expectations, while periods of earnings moderation or concerns over raw material costs have contributed to consolidation in the Neogen Chemicals stock price. Corporate developments, including strategic announcements such as the merger of BuLi Chemicals, the development of a greenfield battery materials facility at Dahej PCPIR, and the expansion into electrolyte manufacturing, have also influenced short-term fluctuations in the Neogen Chemicals price. The Neogen Chemicals share price has shown a 5-year total return of 49.45% according to some sources, while others indicate a 5-year CAGR of 18.51%, reflecting the volatility in the stock. The Neogen Chemicals share price has shown a 10-year aggregate net profit that has grown significantly, reflecting the company’s improving profitability over the long term. The Neogen Chemicals share price reached its 52-week high of 1,797.00 before declining to its 52-week low of 967.00, reflecting the volatility inherent in the specialty chemicals space. The Neogen Chemicals share price has shown a year-to-date return that has been negative as of April 2026. Comprehending these patterns in the Neogen Chemicals share price is instrumental for investors seeking to contextualise long term performance trends vis à vis short term price dynamics, as the Neogen Chemicals price movements illustrate how industry fundamentals, raw material price cycles, and investor expectations converge in market pricing.

The Neogen Chemicals price has shown distinct seasonal patterns over the past decade. The best performing quarter historically has been Q3, with a 5-year average return of 17.75%, while the worst performing quarter was Q1, with a 5-year average return of -8.24%. In terms of annual performance, the Neogen Chemicals share price delivered its strongest annual return of 127.93% in 2021, followed by a positive return of 103.62% in 2020. The stock recorded negative annual returns in 2022 (-25.01%) and 2025 (-45.93%). The year 2026 has shown a negative return of -0.87% year-to-date as of April 2026. The Neogen Chemicals share price has demonstrated that the stock tends to perform better in periods of strong specialty chemical demand and supportive government policies, while underperforming during phases of raw material volatility and intense competition. The Neogen Chemicals stock price has shown a 3-year total return of -7.72%, indicating the challenges faced in the specialty chemicals sector in recent years. The Neogen Chemicals stock price has shown a 10-year total return of 448.65%, reflecting substantial wealth creation over the long term.

Neogen Chemicals Limited Investor Relevance and Role in Portfolio

Neogen Chemicals holds a significant position for portfolio investors who seek exposure to India’s specialty chemicals sector with a focus on bromine and lithium chemistries. The company’s presence in high-growth areas such as lithium-ion battery electrolytes and advanced pharmaceutical intermediates aligns it with investment strategies that value supply chain diversification, import substitution, and the “China+1” theme. The Neogen Chemicals share price often mirrors how these themes resonate with investor portfolios, whereby both thematic and sector specific funds monitor capacity utilization, raw material costs, and order book trends when evaluating allocation decisions.

Institutional stakeholders play a significant role in Neogen Chemicals’s ownership profile. As of December 2025, promoters hold 51.23% of the company. Mutual funds hold 19.82% of the company. Key mutual fund holders include Axis Mutual Fund – Axis Small Cap Fund, SBI Mutual Fund – SBI Large And Midcap Fund, SBI Mutual Fund – SBI Contra Fund, Sundaram Small Cap Fund, Sundaram Long Term Tax Advantage Fund Series III, and other domestic mutual funds. Foreign Institutional Investors (FIIs) hold 4.57% of the company. Domestic Institutional Investors (DIIs) hold 2.17% of the company. Retail and other shareholders hold 22.21% of the company. These investors represent a blend of domestic and international perspectives that contribute to the stock’s market liquidity and visibility within broader investment frameworks.

Based on data, Neogen Chemicals exhibits varying levels of beta and volatility across different measurement periods. Based on data, the long-term beta (5-year) stands at approximately 0.59 according to TradingView, while Simply Wall St reports a beta of -0.10, reflecting different measurement periods and methodologies. Based on data, the daily-one month beta shows low correlation, while the daily-three month beta indicates moderate sensitivity. Based on data, the weekly-one year beta shows lower-than-market sensitivity in short-term trading. Based on data, the weekly-two year beta shows low correlation, and the 2 week-two year range beta is also low. Based on data, the monthly-two year beta continues to show moderate correlation. Supporting statistics include mean values across different periods and standard deviations indicating moderate variability. The weekly volatility stands at approximately 4-5%, which is higher than 75% of Indian stocks. Overall, Neogen Chemicals demonstrates a moderate volatility profile with beta values suggesting the stock tends to move with moderate correlation to broader market direction over certain time frames.

The Neogen Chemicals share price has shown periods of heightened responsiveness to sector-specific news and quarterly earnings releases. The Neogen Chemicals stock price’s beta reflects that the company’s manufacturing nature and established customer relationships may provide some stability, though the specialty chemicals sector remains sensitive to raw material price fluctuations and economic cycles.

Neogen Chemicals Limited Sectoral Relevance and Peer Positioning

The sector relevance of Neogen Chemicals is anchored in its role within the broader Indian specialty chemicals industry, where it competes with other chemical manufacturers. As part of this industry, the company’s strategic positioning connects bromine-based and lithium-based compounds to pharmaceutical, agrochemical, and energy storage applications. Competitors in the specialty chemicals segment include companies such as Aarti Industries Limited, Navin Fluorine International Limited, Himadri Speciality Chemical Limited, Deepak Nitrite Limited, Laxmi Organic Industries Limited, Epigral Limited, and other domestic and international players. Firms with parallels in either product range or technological capabilities are often referenced when evaluating relative performance and operational positioning within the sector.

In valuation terms, factors like the Neogen Chemicals P/E ratio have shown variations over different periods. The mean historical PE Ratio over the last five years has fluctuated significantly, with the current P/E ratio standing at approximately 103-193 across different sources. The P/E ratio was 64.19 in FY2022, 64.11 in FY2021, 88.52 in FY2024, 116.90 in FY2025, and 193.18 in the current period. Periods when investors perceived improvements in profitability or earnings sustainability have corresponded with expansion in valuation multiples, whereas phases of moderation in earnings momentum or industry cyclicality have seen valuation contraction.

Similarly, Neogen Chemicals EPS has shown variation according to how operational performance aligns with industry demand cycles and cost structures. Structural gains from capacity expansion and new product introductions supported directional improvement in earnings per share during favourable conditions, while cyclical headwinds from raw material price volatility and competitive pressures have moderated EPS momentum. Neogen Chemicals earnings have shown a trajectory that responded to both volume growth and margin pressures over the analysed period. Neogen Chemicals market cap has fluctuated in line with investor perceptions of the company’s growth potential in a competitive and evolving specialty chemicals market.

Over years, the Neogen Chemicals market cap has followed a pattern of significant growth followed by moderation. The market cap increased from ₹20,086 million in FY2021 to ₹43,504 million in FY2022, a growth of 116.59%. The market cap then moderated to ₹32,077 million in FY2023 (-26.27%), increased to ₹31,558 million in FY2024 (-1.62%), and then to ₹40,716 million in FY2025 (29.02%). As of April 2026, the market cap stands at approximately ₹3,602-3,813 crore across different sources. This fluctuation mirrors the trend in the Neogen Chemicals share price and the broader performance of the specialty chemicals sector.

Neogen Chemicals earnings over the past several years have been characterised by a period of growth. Net income increased from ₹48 crore in FY2025 (9.87% growth) from ₹44 crore in FY2024, which itself had declined -11.97% from ₹50 crore in FY2023. The company’s revenue grew from ₹691 crore in FY2023 (40.83% growth) to ₹705 crore in FY2024 (1.48% growth) and to ₹783 crore in FY2025 (11.1% growth). This recent earnings growth reflects the impact of strong capacity expansion, strategic acquisitions, and improving operational efficiency. As per Dhan data, quarterly net profit was ₹11 crore in Sep 2024, ₹10 crore in Dec 2024, ₹2 crore in Mar 2025, ₹10 crore in Jun 2025, and ₹3 crore in Sep 2025.

Neogen Chemicals EPS has shown variation over the past decade. The diluted EPS stood at ₹13.20 in FY2025. As per Dhan data, quarterly EPS was ₹4 in Sep 2024, ₹4 in Dec 2024, ₹1 in Mar 2025, ₹4 in Jun 2025, and ₹1 in Sep 2025. The EPS growth rate has shown significant variation, with the company delivering positive profit growth in some years and declines in others. The highest EPS growth rate was achieved in earlier periods, while the lowest was during periods of margin pressure.

The Neogen Chemicals P/E ratio has shown fluctuations over the available period. At the end of recent fiscal years, the P/E ratio varied, with current levels at 103-193x across different sources. The mean historical P/E ratio over the last five years has been elevated. The current P/E ratio compared to the historical average reflects that investor expectations are adjusting to near-term earnings momentum. The Neogen Chemicals share price has been influenced by these valuation metrics. The Neogen Chemicals price continues to be evaluated in the context of its earnings potential and market position.

Summary

Neogen Chemicals Limited is a leading specialty chemicals manufacturer listed on both the NSE and BSE, where the Neogen Chemicals share price reflects bromine and lithium demand trends, capacity expansion, and specialty chemical industry growth. Its representation on stock exchanges supports market visibility, while investor interest is shaped by earnings trends, valuation narratives, and broader chemical industry themes. Within the sector, the company’s competitive context and earnings dynamics provide key perspectives on its role in India’s specialty chemicals market.